NBE
Desconocido
CARAMBA: SLAMF7 CAR T cells prepared by Sleeping Beauty gene transfer for immunotherapy of multiple myeloma...
NBETHERAPEUTICS AG
participó en un
H2020:
H2020-SC1-2016-2017
CARAMBA is proposing to use the revolutionary CAR-T cell technology to tackle multiple myeloma, a rare and incurable hematologic malignancy....
2017-11-22 - 2023-06-30 | Financiado
2017-11-22 - 2023-06-30 | Financiado
MABTOX: Generation and Evaluation of Next generation Antibody Toxin Conjugates for Cancer Therapy
NBETHERAPEUTICS AG
tramitó un
FP7:
Therapeutic antibodies have transformed cancer therapy during the last decade, due to their high selectivity of targeting cancer cells in co...
Financiado
Financiado
* No se disponen de datos de la empresa actual.